These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11997300)

  • 1. Persistent and aggressive bacteria in the lungs of cystic fibrosis children.
    Hart CA; Winstanley C
    Br Med Bull; 2002; 61():81-96. PubMed ID: 11997300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity of microbes associated with cystic fibrosis.
    Hutchison ML; Govan JR
    Microbes Infect; 1999 Oct; 1(12):1005-14. PubMed ID: 10617932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections.
    Tümmler B; Kiewitz C
    Mol Med Today; 1999 Aug; 5(8):351-8. PubMed ID: 10431168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus.
    Schwab U; Abdullah LH; Perlmutt OS; Albert D; Davis CW; Arnold RR; Yankaskas JR; Gilligan P; Neubauer H; Randell SH; Boucher RC
    Infect Immun; 2014 Nov; 82(11):4729-45. PubMed ID: 25156735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis: genome evolution, interactions and adaptation.
    Eberl L; Tümmler B
    Int J Med Microbiol; 2004 Sep; 294(2-3):123-31. PubMed ID: 15493822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Burkholderia cepacia persistence in patients with mucoviscidosis].
    Chernukha MIu; Shaginian IA; Kapranov NI; Alekseeva GV; Kashirskaia NIu; Avetisian LR; Semykin SIu; Danilina GA; Polikarpova SV; Pivkina NV
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (4):93-8. PubMed ID: 22937715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiology of lung infection in cystic fibrosis.
    Govan JR; Nelson JW
    Br Med Bull; 1992 Oct; 48(4):912-30. PubMed ID: 1281036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
    Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
    Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa.
    Hendry J; Elborn JS; Nixon L; Shale DJ; Webb AK
    Eur Respir J; 1999 Aug; 14(2):435-8. PubMed ID: 10515426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of urokinase on the extracellular virulence properties of Pseudomonas aeruginosa and Burkholderia cepacia.
    Heys SJ; Orton SL; Allison DG
    J Basic Microbiol; 1999; 39(1):17-24. PubMed ID: 10071863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequencing of the Pseudomonas aeruginosa and Burkholderia cepacia genomes and their applications in relation to cystic fibrosis.
    Miller DA; Mahenthiralingam E
    J R Soc Med; 2003; 96 Suppl 43(Suppl 43):57-65. PubMed ID: 12906327
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.
    Whiteford ML; Wilkinson JD; McColl JH; Conlon FM; Michie JR; Evans TJ; Paton JY
    Thorax; 1995 Nov; 50(11):1194-8. PubMed ID: 8553277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of "quorum sensing" regulation system in symbiotic interaction of bacteria Burkholderia cepacia and Pseudomonas aeruginosa during mixed infection].
    Chernukha MIu; Shaginian IA; Romanova IuM; Maleev GV; Gintsburg AL
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (4):32-7. PubMed ID: 16941867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.
    Govan JR; Brown AR; Jones AM
    Future Microbiol; 2007 Apr; 2(2):153-64. PubMed ID: 17661652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of mortality in adults with cystic fibrosis.
    Courtney JM; Bradley J; Mccaughan J; O'Connor TM; Shortt C; Bredin CP; Bradbury I; Elborn JS
    Pediatr Pulmonol; 2007 Jun; 42(6):525-32. PubMed ID: 17469153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small Noncoding Regulatory RNAs from
    Pita T; Feliciano JR; Leitão JH
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burkholderia cepacia. Management issues and new insights.
    LiPuma JJ
    Clin Chest Med; 1998 Sep; 19(3):473-86, vi. PubMed ID: 9759550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a PCR probe test for identifying Pseudomonas aeruginosa and Pseudomonas (Burkholderia) cepacia.
    O'Callaghan EM; Tanner MS; Boulnois GJ
    J Clin Pathol; 1994 Mar; 47(3):222-6. PubMed ID: 7512994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiology of cystic fibrosis lung infections: themes and issues.
    Govan JR; Nelson JW
    J R Soc Med; 1993; 86 Suppl 20(Suppl 20):11-8. PubMed ID: 7684788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.